Webcast overview
Peter Mozerov, Roberta Venturi Lechartier and Caroline Chua from KPMG Switzerland will outline the latest trends in European market access, regulatory and tax impacting US-based biotechnology companies, as well as explaining their experiences and best practices of helping biotechnology companies launch and optimize their business and operating models. Topics include IP strategy, financing and cashflow, reimbursement, and importation into Europe.